Connect with us


Why there’s no cause for alarm over new COVID variant



A NEW COVID variant has recently been detected in several countries including the UK, US, India, Australia and Germany.

  Called BA.2.75, it’s a sub variant of omicron. You might have also heard it called “Centaurus”, the name of a constellation and given to BA.2.75 by a Twitter user.

  The World Health Organization has classified BA.2.75 as a variant of interest, rather than a variant of concern. This means it’s being monitored but there’s not yet evidence it will cause problems.

  The numbers of BA.2.75 infections are still relatively low. Most infections in the UK remain driven by the omicron subvariants BA.4 and BA.5. BA.5 in particular is similarly dominant in other countries where BA.2.75 has been detected.

  However, BA.2.75 is becoming more common in India (where it was first detected, back in May), suggesting it has advantages relative to current circulating variants. Some have noted that BA.2.75 is spreading in regions of India where it doesn’t have to compete with BA.5, but rather with the variant it evolved from, BA.2.

  That said, some data from India indicates that BA.2.75 may have already peaked. And importantly, there hasn’t been a big increase in hospitalisations or deaths in India from BA.2.75.

  Given this, BA.2.75 has quickly gained an additional nickname: a “scariant”.

Why are we still seeing new variants?

  As most of the global population has now either been vaccinated, infected, or both, variants which can infect people despite their immunity will have an advantage. So SARS-CoV-2 (the virus that causes COVID) is constantly evolving to gain this advantage.

You May Also Like:-  No vaccine for COVID-19 in Nigeria – WHO

  New variants which have mutations that evade our immunity will replicate and spread, leading to waves of infections. We’ve seen this most recently with BA.4 and BA.5.

  The memory immune system recognises infections based on molecular structures of viruses and other pathogens. Mutations change the molecular structure of each SARS-CoV-2 variant slightly, making it more difficult for our immune system to recognise and respond to the virus. This is often called “immune evasion”.

  The concern around BA.2.75 is that is has picked up a number of mutations, which might indicate that this variant can evade immunity. But there’s no good evidence at this stage that BA.2.75 can evade the immune system in a significant way.

  Most of BA.2.75 is structurally the same as omicron and the original Wuhan variant. Although BA.2.75 has picked up a few mutations, it isn’t fundamentally a different virus.

  The memory immune system will still act against BA.2.75, which is what we’ve seen with omicron. This immunity might not be enough to stop reinfection, but should reduce the severity of a BA.2.75 infection.

  While there are concerns BA.2.75 could spread more quickly than other variants, we don’t have any clear evidence on this yet. It seems to have shown an increase which has levelled off or even dropped relative to a few weeks ago. If this is the case there’s a chance it might even fizzle out in another few weeks.

  But, if BA.2.75 does have some immune evasion properties, it could cause another wave through the UK and elsewhere. Still, this would likely spike and then fizzle out like alpha, delta and omicron BA.1.

You May Also Like:-  COVID-19: Our samples tested negative – Anambra Govt

  Right now, I would put my money on BA.2.75 fizzling out without a major wave of infections. But the next omicron subvariant, and the next pandemic, will inevitably come. New vaccine approaches might make us better prepared.

This error message is only visible to WordPress admins

Error 403: The request cannot be completed because you have exceeded your quota..

Domain code: youtube.quota
Reason code: quotaExceeded

Error: No feed found with the ID .

Go to the All Feeds page and select an ID from an existing feed.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *